blogs.forbes.com — Successful sequels could turn James Cameron's epic into a bankable brand. View in Crawl 4
blogs.forbes.com — Tired of higher rates for pay-TV? Rather than just paying them, why not also collect them as a share View in Crawl 4
blogs.forbes.com — Since today is February 1, 2011, New Year's resolutions are either well underway or broken. I hope y View in Crawl 4
blogs.forbes.com — Microsoft Bill Gates discusses the Internet, Philanthropy and politics with Katie Couric View in Crawl 4
blogs.forbes.com — The lock you see in the picture at right can be found in thousands of locations: hotels, banks, casi View in Crawl 4
blogs.forbes.com — Google is firing back at Microsoft in today's search engine "copygate." A couple of hours ago the bl View in Crawl 4
blogs.forbes.com — Forbes Rich List members say no to Fred Wilpon. View in Crawl 4
forbes.com — Pharma giant Pfizer (PFE) said today its fourth quarter earnings totaled $2. 89 billion, or $0. View in Crawl 4
blogs.forbes.com — Three Russian billionaires seek to block BP's $1.8 billion dividend reinstatement. View in Crawl 4
blogs.forbes.com — I?ll never win a Good Housekeeping award, but when my house does start to look pretty tidy you can bet it?s a sign that I am either expecting guest... View in Crawl 4
blogs.forbes.com — Twenty-three years ago today, on February 1, 1987, a photographer snapped "Weird Al" Yankovic chilling with two members of Run DMC --Darr... View in Crawl 4
blogs.forbes.com — Presidents no longer bother to give objective assessments of America's current and future state. View in Crawl 4
blogs.forbes.com — I didn't talk about diversity or inclusivity in the legal profession for nearly thirty years. Nor di View in Crawl 4
blogs.forbes.com — That?s what the New York Times is asking. During his State of the Union speech, President Obam View in Crawl 4
forbes.com — Orexigen Therapeutics plunges on Tuesday after the FDA denies approval of its new obesity drug. View in Crawl 4